DUBLIN–(BUSINESS WIRE)–The “Drug Discovery Technologies Market – Market Size & Forecasting to 2030” report has been added to ResearchAndMarkets.com’s offering.
The study of the global drug discovery technologies market includes detailed summary, as well as market segmentation, market size, market position, competitive economy, regional and national market analysis, value chain, impact of COVID-19 on global market, trade policy, market strategies of key players, growth trends, opportunities, and optimization.
In the COVID-19 period, the drug discovery technologies market was valued at USD 37,500.3 million in 2021, and it is expected to grow at a CAGR of 6.0% over the forecast period.
The factor driving market growth is the rapid technological advancements for drug discovery. Moreover, growing prevalence of chronic diseases is the leading factor supporting the high demand for drug discovery technologies.
Regional Analysis:
North America, Europe, Asia-Pacific, Middle East and Africa, and South America are the major regions in which the drug discovery technologies market is divided. The growing attention on health and increased government and corporate investment in healthcare are driving demand for drug discovery technology in North America. The governments of the United States and Canada have policies that encourage investors to invest in innovative drug research and development.
Market Segmentation:
For evaluating the micro and macroeconomic aspects that can affect the growth road map, the market research report covers market volume, market share, quantitative and qualitative analysis, and product growth trends study. The market has been segmented based on technology, application, end user, and region.
Key Points of this report:
- Who are the major participants in the drug discovery technologies market industry on a worldwide scale? What are their product specifics, key players, and contact information?
- For the drug discovery technologies market, what technology is used? What is the status of that technology’s advancement?
- What is the present state of the drug discovery technologies market? What is the level of market competition in this industry?
What is the report about?
The competitor data, such as market growth and alliances, is also tracked in the market research report. Analysis of prominent manufacturers’, pricing patterns, and product portfolios allows newcomers to learn about the existing market conditions. The research also discusses the business economy’s core perspective, countries with rapid growth, industry variances, and constraints.
What does this report Provide
- Global market and submarket forecasts, with supporting analysis, for the years 2021 to 2030.
- Analysis of game-changing technological trends and how they will shape the industry
- SWOT analysis of the sector conclusions and suggestions for the market
- Detailed Segmentation to help each stakeholder in market
- 2500+ data points in 60+ tables with focus on historic demand, estimated demand, and demand forecast
- Impact of COVID-19 on demand estimation & forecasts (2020 onward)
- Separate analysis of each segment to understand market deviation due to Covid-19 from 2020 onwards
- Coverage across 5 major regions: North America, Europe, Asia Pacific, Middle East & Africa, and South America
- Country level demand of the 25+ major markets with key trends & factors influencing the same
The drug discovery technologies market report can assist government agencies, state insurance systems, private insurance companies, pharmacists and health-care staff, pharmaceutical industry, wholesalers, regulatory authorities etc.
Key Topics Covered:
1. Market Abstract
2. Market Introduction
3. Research Practice
4. Key Related Data
5. Impact Factor Analysis
6. Market Development Analysis
7. Drug Discovery Technologies Market, by Technology
8. Drug Discovery Technologies Market, by Application
9. Drug Discovery Technologies Market, by End-user
10. Drug Discovery Technologies Market, Regional Analysis
11. Global Drug Discovery Technologies Market, Competitve Intelligence
12. Company Profiles
13. Appendix
Companies Mentioned
- Bio-Rad Laboratories Inc.
- Perkinelmer Inc. Incyte
- Gyros Protein Technologies
- Evotec
- Thermo Fisher Scientific Inc.
- Agilent Technologies Inc.
- Astrazeneca
- F. Hoffmann- La Roche Ltd.
- Merck Kgaa
- Charles Laboratories International Inc.
- Tecan
- Shimadzu Corporation
- Eurofins Scientific
- Chembridge Corporation
For more information about this report visit https://www.researchandmarkets.com/r/jakmbu
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900